Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |